12-120739194-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000017.4(ACADS):c.1084C>T(p.Gln362Ter) variant causes a stop gained, splice region change. The variant allele was found at a frequency of 0.00000372 in 1,613,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000017.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADS | NM_000017.4 | c.1084C>T | p.Gln362Ter | stop_gained, splice_region_variant | 9/10 | ENST00000242592.9 | NP_000008.1 | |
ACADS | NM_001302554.2 | c.1072C>T | p.Gln358Ter | stop_gained, splice_region_variant | 9/10 | NP_001289483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACADS | ENST00000242592.9 | c.1084C>T | p.Gln362Ter | stop_gained, splice_region_variant | 9/10 | 1 | NM_000017.4 | ENSP00000242592 | P1 | |
ACADS | ENST00000411593.2 | c.1072C>T | p.Gln358Ter | stop_gained, splice_region_variant | 9/10 | 2 | ENSP00000401045 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000809 AC: 2AN: 247164Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134740
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460740Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 726690
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74496
ClinVar
Submissions by phenotype
Deficiency of butyryl-CoA dehydrogenase Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 23, 2022 | This variant is present in population databases (rs541587321, gnomAD 0.007%). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ACADS protein in which other variant(s) (p.Arg386Cys) have been determined to be pathogenic (PMID: 16906473; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 370099). This variant has not been reported in the literature in individuals affected with ACADS-related conditions. This sequence change creates a premature translational stop signal (p.Gln362*) in the ACADS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 51 amino acid(s) of the ACADS protein. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Nov 19, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at